SAN JOSE, Calif., Sept. 14, 2011 /PRNewswire/ — Teikoku Pharma
USA, Inc., (“TPU”) is pleased to announce an exclusive license
agreement with Verde Environmental Technologies Inc. (“Verde”), a
company aimed at developing environmentally responsible solutions
for pharmaceutical disposal. Verde is a privately held
company, founded by former executives of TPU and Travanti Pharma,
Verde obtained rights to develop products, which are designed to
adsorb and inactivate the active ingredients in pills, tablets,
capsules and topical patches, in a convenient and environmentally
responsible manner, based on patented technology developed and
owned by TPU.
“We are very pleased that these new product ideas that were
generated from our research led to this important new development,
stated TPU CEO, Masahisa Kitagawa. TPU located in San Jose,
California is the US operations of Teikoku Seiyaku Co., Ltd., one
of the world’s largest manufacturers of medicated patches based in
Japan, and its product, Lidoderm, is a leading global brand.
“The products being developed by Verde will address the growing
issue of pharmaceutical contamination of groundwater supplies.
By providing an effective means of adsorbing the active
ingredients, this will help keep waste pharmaceuticals from
appearing in the water supply,” stated Verde Chairman and CEO, Dr.
Andrew Korey. “In addition, these developments will provide
anti-abuse features, and improved safety, by diminishing the risk
of accidental poisoning from active pharmaceuticals disposed in
Teikoku Pharma USA Inc., a wholly-owned subsidiary of Teikoku
Seiyaku Inc. of Japan, is a specialty pharmaceutical company that
develops, and manufactures enhanced pharmaceutical products based
on its transdermal drug delivery technologies. Teikoku focuses its
efforts in two therapeutic areas; Pain Management and CNS.
Teikoku’s main product is Lidoderm® (Lidoca